4Fung SK,Lok AS.Management of hepatitis B patients with antiviral resistance[J].Antivir Ther,2004,9:1013-1026.
5Peters MG,Hann Hw H,Martin P,et al.Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B[J].Gastroenterology,2004,126:91-101.
5Stoop JN,van der Molen RG,Kuipers EJ,et al.Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B[J].Virology,2007,361(1):141-148.
6Chan HL,Heathcote EJ,Marcellin P,et al.Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir:a randomized trial[J].Ann Intern Med,2007,147(11):745-754.
7Leung N.Recent data on treatment of chronic hepatitis B with nucleus tide analogues[J].Hepatol Int,2008,2(2):163-178.
8Piccolo P,Lenci I,Demelia L,et al.A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B[J].Antivir Ther,2009,14(8):1165-1174.
10Lee JM,Park JY,Kim do Y,et al.Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B[J].Antivir Ther,2010,15(2):235-241.
